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Introduction
The painful ophthalmoplegia syndrome is a condition which involves periorbital or hemicranial pain combined with ipsilateral paralysis of the common oculomotor nerve and loss of sensitivity in the distribution of the ophthalmic branch and/or maxillary of the trigeminal nerve. [1] Painful ophthalmoplegia can result from neoplasic, vascular, inflammatory or infectious disease. [2] Tolosa-Hunt syndrome (THS) is one of the uncommon reason of painful opthalmoplejia.
According to the International Headache Society Classification of 2004, THS is an entity that occurs rarely, its etiopathogenesis is unknown, it is manifested clinically by unilateral orbital pain associated with simple or multiple oculomotor paralyses, which resolves spontaneously but may recur. MRI orbital phlebography and biopsy are the recommended methods for making diagniosis. [3] The clinical presentation of THS has a wide differential diagnosis, can Herein we report a 45-year-old women with painful ophthalmoplegia of the left eye secondary to the THS, it's diagnostic procedures and treatment.
Painful ophthalmoplegia: a case report and literature review

Case Report
A 45-year-old women was first seen in emergengcy department with severe pain behind the left eye, numbness of the left side of the face, and diplopia.. The pain was over the left eyebrow, nose and nose wing root and started 4 mounths ago. Her attacks was abrupt, brief, lasting only seconds but becoming more frequent over time. She described as heavy, stabbing and burning. Symptoms were poorly controlled with antibiotics and nonsteroidal anti-inflammatory drugs. Cranial MRI and intra-extracarnial MR Anjiography was normal in the first month. Gabapentin 600 mg/day was started but all this treatments have failed. Whereupon carbamazapine 400 mg/day was started, 3 day later increased to 800 mg/ day. The patient's pain improved with this treatment. But during the first week of drug continuous throbbing pain behind his left eye started when she wake up in the morning. After 3 days later the patient was admitted to the hospital. In emergency room her vitals were normal. Examination showed periorbital oedema and left palpebral semiptosis, paresis of the partial left third nerve palsy with normal pupillary reactions, fourth and sixth left cranial nerves, and hypoesthesia over the first and second division of the left trigeminal nevre (Figure 1 ).
Visual acuity and the fundus was normal. There was no proptosis, and the rest of the neurological and systemic examination was normal. Her relevant medical history only included smoking 20 packs/ years. She had not history of headaches, diabetes mellitus, hipertansiyon or any anohter illness.
OCTOBER 2015 220 PAIN A RI We performed the following complementary studies: normal hemogram and biochemistry including glucose level, normal basic coagulation, ESR, lues serology and vasculitis markers. Thyroid function tests showed TSH: 9.6 μUI/ml (0.34-5.60), free T4: 0.40 ng/ dl [0.54-1.64]. Anti-thyroglobulin, anti-microsomal and anti-thyrotropin receptor were normal. An urgent cranial computed tomography (CT) scan of brain and paranasal sinus, were normal. The cranial MRI with a study in T1-T2 weighted sequences, with gadolinium in both orbits, and MR-Anjiography of the brain were normal, no evidence of alterations in the cavernous sinus (Figures 2a, b) . A spinal tap was performed. CSF yielded normal opening pressure, cellularity, glucose, proteins and red blood cells. Normal supraaortic trunks duplex. She had newly diagnosed, untreated hypothyroidism but thyroidassociated orbitopathy were excluded. Because her pain's character was neuropathic, hypothyroidism was not autoimmune and ocular manifestations and orbital imaging were not typical for Graves' ophthalmopathy. Since the studies showed no abnormalities and we excluded neoplasic, infectious, vascular and metabolic causes of her painful ophthalmoplegia caused by the THS. Our patient with idiopathic painful ophthalmoplegia fulfilled THS criteria (A, B, C, D and E) ( Table 1) . Her treatment for THS was started with methylprednisolone 1 gr intravenous/day for 5 days, and noticed significant improvement in terms of the left periorbital pain and the ipsilateral ocular motor nerve palsies in the next 48 hours. Then at day 6, she received 60 mg of methylprednisolone per os (1 mg/kg/day). One week later, she initiated steroid tapering every week and the dose was gradually decreased for 2 months. The newly diagnosed hypothyroidism was treated by Eutrox 50 mg/day. Upon completion of treatment, full remission of the condition was attained, the patient was asymptomatic and her neuro-ophthalmologic examination was completely normal (Figure 3 ).
Discussion
In our patient her full blood count, biochemistry, brain and sinus CT, brain and orbital MRI with gadolinium, MR-anjiography and CSF were normal. She had newly diagnosed, untreated hypothyroidism Painful ophthalmoplegia but thyroid-associated orbitopathy were excluded. Because her pain's character was neuropathic, her hypothyroidism was not autoimmune and ocular manifestations and orbital imaging were not typical for Graves' ophthalmopathy. So the case described herein corresponds to an orbital involvement which suggested involvement of the cavernous sinus due to an associated inflammatory disease. We thought that the patient had THS because she completely fulfilled HIS 2004 diagnostic criteria, and since without significant findings in the in her neuroimaging and CSF, she had a benign variety of THS.
Painful ophthalmoplegia often refers to a multiple cranial nerve syndrome involving the oculomotor, trochlear, and abducens nerves and the ophthamic division of the trigeminal nerve. Various etiologies have been reported; these include infections, inflammations, granulomatous process, sphenoid sinus mucocele, local tumors, dural arteriovenous malformation, trauma, and diabetes mellitus. [5] Unilateral painful ophthalmoplegia can be acute, chronic, relapsing, and remitting [spontaneusly or in association with steroid withdrawal and treatment] or progressive. [6] Tolosa-Hunt syndrome is a rare disorder indicated by recurrent painful ophthalmoplegia caused by nonspecific inflammation of the cavernous sinus or superior orbital fissure. Tolosa first described the condition in 1954, in a patient with unilateral recurrent painful ophthalmoplegia involving cranial nerves III, IV, VI and V1. The patient was imaged using carotid angiography, and segmental narrowing of the carotid siphon was seen. [7] Hunt et al. described 6 patients with similar clinical findings in 1961, and proposed a low-grade non-specific inflammation of the cavernous sinus and its walls as the cause of the syndrome. [8] Painful ophthalmoplegia secondary to idiopathic granulomatous inflamation of the cavernous sinus or the superior orbital fissure that is steroid responsive was given the eponym THS by Smith and Taxdal in 1966. [5] Pathologically, infiltration of lymphocytes and plasma cells as well as thickening of the dura mater was seen. [4, 7, 8, 9] Clinically, the hallmark of this disorder is pain, which can be severe or a deep ache associated varying degrees of ophthalmoplegia, ptosis and diplopia. The symptoms and signs depend on the location of inflammation. If the orbit is involved, conjunctival injection avd chemosis, orbital conjection and proptosis, lacrimal gland injection and swelling can be observed. Immediate response to steroid therapy is a hallmark of the condition. THS criteria was first provided by the International Headache Society [IHS] in 1988, [10] and modified ( [6] Neuroimaging and CSF are important in differantial diagnosis. Also full blood count, ESR, C reactive protein, full biochemistry tests including thyroid and liver functional tests, Chest X ray and Sinus CT may also be indicated. Barin and orbital imaging includes MRI and CT scan. MRI (T2-weighted including fat suppression STIR Sequence) helps to identify high signals in an active extra-ocular muscle. Inflammatory causes of painful ophthalmoplegia include those due to a specific infectious agent. It is essential that careful CSF examination be done and that cultures (bacterial, fungal, mycobacterial) be obtained.
The management of patients with painful ophthal-mopathy is complex and challenging. Neurologists, ophthalmologists, pathologists and neuroradiologists all play important roles in establishing the correct diagnosis. The THS diagnosis should be used rarely and with great caution, as most cases are ultimately attributable to defined disease processes such as infection, granulomatous inflammation or neoplasm. That patients suspected of having the syndrome require careful evaluation, appropriate treatment, and scrupulous follow up observation. [12] Conflict-of-interest issues regarding the authorship or article: None declared.
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